A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy

NCT00644748 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies

Interventions

DRUG: gabapentin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.